In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
400 News Items found
PhD candidate Laura Menocal wearing a mask in the lab
The Path Ahead: How MSK Responded to COVID-19

Learn how Memorial Sloan Kettering Cancer Center kept caring for patients during the response to COVID-19, and how lessons learned during the pandemic are helping cancer care.
A Hodgkin lymphoma survivor who received nivolumab as part of a clinical trial.
In the Clinic
Immunotherapy Drug Approved for Treatment of Hodgkin Lymphoma

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.
Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
In the Lab
Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain?

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.
Pictured: Joan Massagué
Announcement
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
Cancer biologist and pediatric oncologist Alex Kentsis
Science Byte
Blocking Enzymes That Signal DNA Damage Could Be a Treatment Strategy for Childhood Cancers

A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA.
Gerstner Sloan Kettering Students
8 Gerstner Sloan Kettering Students Prepare To Graduate

Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.
Pictured: Ping Chi
Q&A
At Work: Physician-Scientist Ping Chi

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.
Family of four sitting and smiling for camera.
Metastatic Breast Cancer and Motherhood: Staying Hopeful

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Imaging test
Q&A
CT Scan Safety: A Radiation Reality Check

Medical physicist Lawrence Dauer explains what you should know about the use and safety of tests such as CT scans that use radiation to obtain images of the body.
Dandelion
Seed and Soil: Tracing the Journey of Spreading Cancer Cells

MSK researchers are learning more about how cancer cells can survive undetected for years only to return in new places. These insights will guide future therapies.